4
$SSOLFDWLRQVFOLQLTXHV
,QGLFDWLRQV
/HPDWHODV
Alpha Active 4
HVWLQGLTXpGDQVOHFDGUHGHODSUpYHQ
WLRQHWRXGHODJHVWLRQGHWRXWHVOHVFDWpJRULHV
G¶HVFDUUHVGDQV
OHFDGUHGXQSURWRFROHFRPSOHWHWLQGLYLGXDOLVpGHSUpYHQWLRQGHV
HVFDUUHV SDUH[HPSOHUHSRVLWLRQQHPHQWVRXWLHQQXWULWLRQQHOHW
VRLQGHODSHDX/DVpOHFWLRQGRLWVHEDVHUVXUXQHpYDOXDWLRQ
KROLVWLTXHGHVEHVRLQVLQGLYLGXHOVGXSDWLHQWHQPDWLqUHGHVRLQV
/HVGLVSRVLWLIVUHSUpVHQWHQWO¶XQGHVDVSHFWVGXSURWRFROHGH
JHVWLRQGHVHVFDUUHV,ODSSDUWLHQWDXPpGHFLQSUHVFULSWHXU
G¶HQYLVDJHUWRXVOHVDXWUHVDVSHFWVGHVVRLQV
6LOHVSODLHVH[LVWDQWHVQHV¶DPpOLRUHQWSDVRXVLO¶pWDWGHVDQWp
GXSDWLHQWpYROXHOHPpGHFLQSUHVFULSWHXUGHYUDUHFRQVLGpUHUOH
WUDLWHPHQWJOREDO
/HVLQGLFDWLRQVFLGHVVXVFRQVWLWXHQWXQLTXHPHQWGHVUHFRP
PDQGDWLRQVHWQHGRLYHQWSDVUHPSODFHUXQMXJHPHQWFOLQLTXH
/HPDWHODV
Alpha Active 4
HVWFRQoXSRXUGHVSDWLHQWVSHVDQW
MXVTXj NJ OE
&RQWUHLQGLFDWLRQV
1XWLOLVH]SDVOHGLVSRVLWLI
Alpha Active 4
SRXUGHVSDWLHQWV
DWWHLQWVGHIUDFWXUHVLQVWDEOHVGHODFRORQQHYHUWpEUDOH
3UpFDXWLRQV
6LOHVSDWLHQWVSUpVHQWHQWG¶DXWUHVIUDFWXUHVLQVWDEOHVRXELHQXQ
pWDWVXVFHSWLEOHGHFRPSOLFDWLRQVXUXQHVXUIDFHPROOHRXHQ
PRXYHPHQWXQDYLVPpGLFDOHVWQpFHVVDLUHDYDQWXWLOLVDWLRQ
0rPHVLOHGLVSRVLWLI
Alpha Active 4
DpWpFRQoXSRXUSRUWHUGHV
SDWLHQWVMXVTXDX[OLPLWHVGHSRLGVLQGLTXpHVFLGHVVXVLOHVW
SRVVLEOHTXHFHX[GRQWOHSRLGVHVWSURFKHGXVHXLODLHQWGDXWUHV
EHVRLQVHQPDWLqUHGHVRLQVHWGHPRELOLWp'DQVFHVFDVOj
XQ GLVSRVLWLIVSpFLDOSRXUSHUVRQQHREqVHVHUDLWSHXWrWUHSOXV
DSSURSULp
1. Directive internationale NPUAP/EPUAP sur la prévention et le traitement des escarres, 2014.
5(0$548(
Ces indications font uniquement office d’instructions générales
et ne doivent en aucun cas remplacer un avis ou une expé-
rience clinique.
Содержание Alpha Active 4
Страница 158: ...23 HORZR SXVWH...